BACKGROUND. A Nomogram based on pretreatment prostate specific antigen (
Evaluation of artificial neural networks for the prediction of pathologic stage in prostate carcinoma
โ Scribed by Misop Han; Peter B. Snow; Jeffrey M. Brandt; Alan W. Partin
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 104 KB
- Volume
- 91
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The application of arti"cial neural networks (ANNs) for prognostic and diagnostic classi"cation in clinical medicine has become very popular. In particular, feed-forward neural networks have been used extensively, often accompanied by exaggerated statements of their potential. In this paper, the ess
## BACKGROUND. Our purpose was to compare the importance of over 22 measurements used in evaluating the clinical responses of patients with metastatic or locally recurrent prostate cancer, treated by dendritic cell (DC) infusions with prostate-specific membrane antigen (PSMA) peptides. METHODS. Art
## BACKGROUND. Accurate examination of radical cystectomy specimens is critical for stratifying patients into prognostically important groups and determining the need for adjuvant treatment. Evidence has accumulated that cancers invading the superficial muscle wall (T2a) behave similarly to those
## BACKGROUND. The current study assesses artificial intelligence methods to identify prostate carcinoma patients at low risk for lymph node spread. If patients can be assigned accurately to a low risk group, unnecessary lymph node dissections can be avoided, thereby reducing morbidity and costs.
## BACKGROUND. The 1997 American Joint Committee on Cancer (AJCC) staging system condensed unilobular tumors into one entity and continues the use of both imaging and biopsy to alter classification status in T2 and T3 carcinomas. This study analyzes the biochemical freedom from disease recurrence